Astellas Pharma's net profit FY 2008-2017
Net income of Astellas Pharma Inc. from fiscal year 2008 to 2017 (in billion Japanese yen)
This statistic depicts the net income of the Japanese pharmaceutical company Astellas Pharma Inc. from fiscal year 2008 to 2017. In fiscal year 2017, Astellas Pharma's net income amounted to approximately 204.3 billion Japanese yen, decreased from around 213.3 billion yen in the previous fiscal year.
Net income of Astellas Pharma Inc. from fiscal year 2008 to 2017 (in billion Japanese yen)
Source
More information
Statistics on "Pharmaceutical trends in Europe"
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Astellas Pharma's R&D expenditure FY 2008-2017
- Astellas Pharma's total assets FY 2008-2017
- Astellas Pharma's operating profit FY 2008-2017
- Italy: tangible investments of leading pharmaceutical companies 2009-2016
- Italy: international turnover of leading pharmaceutical companies 2007-2017
- Italy: perception of pharmaceutical companies 2018, by brand
- Revenue of the top ten pharmaceutical companies in France 2016
- Italy: turnover of foreign invested enterprises of pharmaceuticals 2009-2015
- Italy: workforce of leading pharmaceutical companies 2014-2016, by department
- Top U.S. states by financial penalties for pharmaceutical companies 1991-2015
- Top pharmaceutical companies in Argentina 2014 by revenue
- Pharmaceutical industry settlements number - state and federal governments 1991-2015
- Current and future value for pure play pharmaceutical companies 2005-2013
- Top pharmaceutical companies in Canada by market share 2016
- Net profit of Roche Farma SA in Spain 2013-2016
- Italy: workforce of leading pharmaceutical companies 2007-2017
- Hanmi Science net income 2017-2018
- Leading Japanese pharmaceutical companies 2014, by revenue
Statistics on "Pharmaceutical trends in Europe"
Related topics
About Statista
